Literature DB >> 6600583

Risk for liver disease in adults with alpha 1-antitrypsin deficiency.

D W Cox, S Smyth.   

Abstract

Risk for the development of liver disease was estimated in 115 adults with alpha 1-antitrypsin deficiency, most of whom were of PI type (protease inhibitor type) Z. Seventy-one subjects were ascertained through their disease; 44 were ascertained independently of disease. A low concentration of serum prealbumin was sensitive in detecting impaired liver function and may indicate functioning cell mass, a different parameter than is measured by liver enzymes. Liver disease has usually been considered rare in adults with alpha 1-antitrypsin deficiency. However, the risk for the development of liver disease was relatively high for men between 51 and 60 years of age. The risk for women was lower than that for men. Our study indicates that a periodic assessment of liver function may be warranted for patients with alpha 1-antitrypsin deficiency who are over 40 years of age.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600583     DOI: 10.1016/0002-9343(83)90615-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  15 in total

Review 1.  Diagnosis and management of patients with α1-antitrypsin (A1AT) deficiency.

Authors:  David R Nelson; Jeffrey Teckman; Adrian M Di Bisceglie; David A Brenner
Journal:  Clin Gastroenterol Hepatol       Date:  2011-12-23       Impact factor: 11.382

Review 2.  Single gene disorders affecting the gastrointestinal tract.

Authors:  G R Taylor; S M Farmery
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

Review 3.  Macrophage activation, chronic inflammation and gastrointestinal disease.

Authors:  A R Tanner; M J Arthur; R Wright
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

4.  Orthotopic liver transplantation for alpha-1-antitrypsin deficiency: an experience in 29 children and ten adults.

Authors:  C O Esquivel; E Vicente; D Van Thiel; R Gordon; W Marsh; L Makowka; B Koneru; S Iwatsuki; M Madrigal; M A Delgado Millan
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

Review 5.  Aetiology and pathophysiology of chronic liver disorders.

Authors:  J Schölmerich; A Holstege
Journal:  Drugs       Date:  1990       Impact factor: 9.546

6.  Low yield and utilization of confirmatory testing in a cohort of patients with liver disease assessed for alpha-1 antitrypsin deficiency.

Authors:  Elliot B Tapper; Vilas R Patwardhan; Michael Curry
Journal:  Dig Dis Sci       Date:  2014-12-23       Impact factor: 3.199

7.  Lack of association between HLA antigen DR3 and alpha 1-antitrypsin deficiency in liver transplant recipients.

Authors:  A Casavilla; R Gordon; D H van Thiel; T E Starzl
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

8.  Liver test results do not identify liver disease in adults with α(1)-antitrypsin deficiency.

Authors:  Virginia C Clark; Renumathy Dhanasekaran; Mark Brantly; Farshid Rouhani; Pamela Schreck; David R Nelson
Journal:  Clin Gastroenterol Hepatol       Date:  2012-07-24       Impact factor: 11.382

Review 9.  Alpha-1-antitrypsin deficiency: current concepts.

Authors:  Alan T Mulgrew; Clifford C Taggart; N Gerry McElvaney
Journal:  Lung       Date:  2007-06-12       Impact factor: 2.584

10.  Late manifestation of chronic liver disease in adults with alpha-1-antitrypsin deficiency.

Authors:  J Rakela; M Goldschmiedt; J Ludwig
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.